PALOMA3_2A: PALOMA3, figure 2A

PALOMA3_2AR Documentation

PALOMA3, figure 2A

Description

Kaplan-Meier digitized data from PALOMA3, figure 2A (PMID 26947331). A reported sample size of 521 for a primary endpoint of PFS in breast cancer.

Usage

PALOMA3_2A

Format

A data frame of 521 observations and 3 variables:

time event time (in months)
event PFS event indicator (0: no event, 1: event)
arm treatment arms (fulvestrant_palbociclib, fulvestrant_placebo)

Source

Cristofanilli M, Turner NC, Bondarenko I, et al. Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial. Lancet Oncol 2016; 17: 425–39.

Examples

summary(PALOMA3_2A)

kmplot(PALOMA3_2A)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.